Price
Financials
Consolidated, Rs crore| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 48 | 55 | 60 | 57 | 62 | 61 | 66 | 72 | 66 | 74 | 75 |
| Expenses | 44 | 43 | 46 | 48 | 52 | 51 | 54 | 61 | 59 | 60 | 60 |
| Operating Profit | 4 | 12 | 14 | 9 | 10 | 10 | 12 | 11 | 7 | 14 | 14 |
| OPM % | 8% | 21% | 23% | 15% | 16% | 16% | 18% | 15% | 11% | 18% | 19% |
| Other Income | -0 | -0 | 6 | 1 | 1 | 2 | 2 | 2 | -4 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | -1 | 7 | 16 | 5 | 5 | 6 | 10 | 9 | -1 | 11 | 12 |
| Tax % | -140% | 16% | 11% | 23% | 23% | 41% | 24% | 20% | -175% | 4% | 21% |
| Net Profit | 2 | 8 | 17 | 6 | 5 | 4 | 8 | 9 | 2 | 10 | 10 |
| EPS in Rs | 74.05 | 243.91 | 6.04 | 2.12 | 0.93 | 0.78 | 1.53 | 1.55 | 0.36 | 1.83 | 1.87 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 150 | 92 | 137 | 162 | 194 | 239 | 278 | 287 |
| Expenses | 146 | 88 | 130 | 152 | 169 | 196 | 234 | 241 |
| Operating Profit | 3 | 4 | 7 | 9 | 24 | 43 | 44 | 46 |
| OPM % | 2.3% | 4.6% | 4.8% | 6% | 13% | 18% | 16% | 16% |
| Other Income | 2 | 0 | -10 | 2 | 0 | 10 | 3 | 3 |
| Interest | 3 | 3 | 4 | 4 | 6 | 6 | 2 | 1 |
| Depreciation | 7 | 6 | 8 | 11 | 12 | 15 | 16 | 17 |
| Profit before tax | -4 | -4 | -16 | -5 | 7 | 31 | 29 | 31 |
| Tax % | 5% | 8% | 15% | 4% | -136% | 21% | 9% | |
| Net Profit | -5 | -5 | -19 | -4 | 25 | 32 | 29 | 31 |
| EPS in Rs | -154.92 | -156.22 | -596.62 | -128.94 | 804.81 | 5.78 | 5.27 | 5.61 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 25% | 20% | 17% | ||
| Compounded Profit Growth | % | 103% | 124% | 50% | ||
| Stock Price CAGR | % | % | % | -40% | ||
| Return on Equity | % | 18% | 22% | 15% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 11 | 11 |
| Reserves | 37 | 33 | 9 | 6 | 31 | 198 | 232 |
| Borrowings | 37 | 39 | 50 | 50 | 61 | 20 | 13 |
| Other Liabilities | 31 | 34 | 43 | 40 | 46 | 60 | 40 |
| Total Liabilities | 106 | 106 | 103 | 97 | 139 | 288 | 297 |
| Fixed Assets | 39 | 42 | 40 | 40 | 46 | 51 | 63 |
| CWIP | 0 | 7 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 | 10 | 27 |
| Other Assets | 66 | 56 | 63 | 56 | 87 | 227 | 207 |
| Total Assets | 106 | 106 | 103 | 97 | 139 | 288 | 297 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 12 | 10 | -2 | 14 | 8 | 44 | -5 |
| Cash from Investing Activity | -18 | -9 | 3 | -10 | -11 | -29 | -78 |
| Cash from Financing Activity | 6 | -0 | -4 | -1 | -3 | 111 | -18 |
| Net Cash Flow | 0 | 0 | -3 | 3 | -5 | 125 | -101 |
| Free Cash Flow | -5 | 0 | -0 | 5 | -5 | 28 | -23 |
| CFO/OP | 357% | 226% | -30% | 157% | 38% | 109% | 4% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 64 | 54 | 46 | 47 | 56 | 60 |
| Inventory Days | 186 | 305 | 272 | 212 | 397 | 156 | |
| Days Payable | 197 | 273 | 245 | 197 | 585 | 68 | |
| Cash Conversion Cycle | 54 | 96 | 81 | 61 | 47 | -132 | 147 |
| Working Capital Days | 13 | 3 | -3 | -13 | 0 | 37 | 182 |
| ROCE % | 3% | -1% | 1% | 18% | 19% | 15% |
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 41.70% | 41.70% | 41.70% | 41.70% | 41.77% | 41.80% |
| FIIs | 34.24% | 33.59% | 32.39% | 32.45% | 31.20% | 30.10% |
| DIIs | 12.86% | 14.30% | 11.85% | 10.82% | 10.52% | 10.89% |
| Public | 11.19% | 10.39% | 14.05% | 15.01% | 16.50% | 17.21% |
| No. of Shareholders | 29,482 | 27,957 | 37,909 | 38,635 | 38,161 | 36,937 |
Fundamentals
Market Cap₹ 1,058 Cr.
Current Price₹ 192
Stock P/E30.4
Book Value₹ 44.3
ROCE15.0 %
ROE14.8 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)17%
Compounded Profit Growth (TTM)50%
Consolidated figures.
Valuation
Market capRs 1,066 Cr
Enterprise valueRs 1,115 Cr
P/E (TTM)34.50x
Price to book172.73x
Price to sales3.71x
EV / EBITDA22.65x
EV / EBIT34.21x
EV / sales3.88x
Price to cash flow73.81x
Earnings yield2.90%
Profitability
Operating margin (excl. other income)5.79%
Operating margin (incl. other income)6.74%
EBITDA margin17.15%
Pre-tax margin10.93%
Net profit margin10.76%
Net margin, latest quarter13.79%
ROE-50.86%
ROCE-0.17%
ROA-3.98%
ROE, 3-year average-50.48%
ROCE, 3-year average-6.99%
ROA, 3-year average-8.72%
ROIC (approx.)61.79%
Tax rate-4.16%
Other income / net worth24.80%
Growth
Sales growth (latest year)18.12%
Sales CAGR, 3 years2.57%
Sales growth QoQ1.01%
Profit growth QoQ2.18%
Sales growth YoY (latest quarter)13.87%
Profit growth YoY (latest quarter)22.77%
Per share
EPS (TTM)Rs 5.62
EPS (latest year)Rs -128.93
EPS (latest quarter)Rs 1.87
EPS, 3-year averageRs -293.91
Book value per shareRs 1.12
Sales per shareRs 52.20
Cash flow per shareRs 2.63
Free cash flow per shareRs -4.18
Efficiency
Asset turnover1.67x
Fixed asset turnover4.03x
Inventory turnover2.10x
Inventory days174 days
Debtor days46 days
Debtors turnover7.92x
Creditor days68 days
Cash conversion cycle147 days
Working capital days182 days
Leverage
Total debtRs 50 Cr
Cash and bankRs 2 Cr
Net debtRs 49 Cr
Debt to equity8.16x
Net debt / EBITDA0.99x
Interest coverage26.93x
Current ratio (filing 2026-03-31)6.21x
Quick ratio (filing 2026-03-31)5.51x
Trade payables (filing 2026-03-31)Rs 11 Cr
Owners' fund to total sources6.39%
Debt to assets52.13%
Cash flow
Cash from Operating Activity (latest year)Rs 14 Cr
Cash from Investing Activity (latest year)Rs -10 Cr
Cash from Financing Activity (latest year)Rs -1 Cr
Net Cash Flow (latest year)Rs 3 Cr
Free cash flow (latest year)Rs -23 Cr
FCFE (approx.: FCF + change in debt)Rs -23 Cr
Cash from ops / profit, 5 years0.94x
Sales to cash flow11.19x
Statement figures
Net sales (TTM)Rs 287 Cr
Net sales (latest year)Rs 162 Cr
Sales (latest quarter)Rs 75 Cr
Operating profit excl. other income (latest year)Rs 9 Cr
Operating profit (latest quarter)Rs 14 Cr
Other income (TTM)Rs 3 Cr
EBITDA (TTM)Rs 49 Cr
PBDT (TTM)Rs 48 Cr
Profit before tax (TTM)Rs 31 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 31 Cr
Net profit (latest year)Rs -4 Cr
Net profit (latest quarter)Rs 10 Cr
Depreciation (TTM)Rs 17 Cr
Depreciation (latest quarter)Rs 4 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 51 Cr
Total expenditure (latest year)Rs 152 Cr
Total income (latest year)Rs 163 Cr
Share capitalRs 0 Cr
ReservesRs 6 Cr
Shareholders' fundsRs 6 Cr
Total assetsRs 97 Cr
Net blockRs 40 Cr
InvestmentsRs 0 Cr
ReceivablesRs 20 Cr
InventoryRs 24 Cr
Other liabilitiesRs 40 Cr
Shares outstanding (crore)5.50
Ownership
Promoter holding41.80% (+0.10 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | LAXMIDENTL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.6% | -2.8% | +1.2 pts |
| 1 month | +0.5% | -6.8% | +7.3 pts |
| 3 months | -15.0% | -7.6% | -7.4 pts |
| 6 months | +22.5% | +0.4% | +22.1 pts |
| 1 year | -39.7% | -9.9% | -29.8 pts |
18 mutual fund schemes hold about ₹105 Cr.
Over three months 2 bought more and 8 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| ICICI Pru Healthcare Fund- | 0.67% | 47 | +2% |
| UTI Healthcare Fund | 0.98% | 14 | +12% |
| HDFC Pharma and Healthcare Fund | 0.38% | 13 | -19% |
| Bank of India Small Cap Fund | 0.27% | 9 | -20% |
| Tata ELSS-Tax Saver Fund | 0.12% | 5 | -1% |
| DSP Healthcare Fund | 0.14% | 5 | -7% |
| WOC Multi Cap Fund | 0.06% | 2 | -10% |
| WOC Pharma and Healthcare Fund | 0.24% | 2 | +33% |
| HDFC Consumption Fund | 0.21% | 2 | -0% |
| Kotak Healthcare Fund | 0.17% | 1 | -79% |
| Tata India Innovation Fund | 0.07% | 1 | +5% |
| WOC Balanced Advantage Fund | 0.03% | 1 | -3% |
| WOC Multi Asset Allocation Fund | 0.01% | 1 | -6% |
| ICICI Pru Exports & Services Fund | 0.03% | 1 | -92% |
| ICICI Pru Exports & Services Fund | 0.03% | 0 | -92% |
| Bank of India Conservative Hybrid Fund(A | 0.12% | 0 | +2% |
| WOC Balanced Hybrid Fund | 0.01% | 0 | +2% |
| Bandhan BSE Healthcare Index Fund | 0.02% | 0 | -4% |
Red flags
F-score 6 of 8| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹75 Cr +13.6% vs Jun 2025.
Net profit ₹10 Cr +25.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Poly Medicure Ltd | 16,671 | 52.1 | 12.5 % |
| Molbio Diagnostics Ltd | 14,470 | 66.6 | 18.0 % |
| Fischer Medical Ventures Ltd | 2,355 | 96.2 | 11.4 % |
| Tarsons Products Ltd | 1,754 | 148 | 4.59 % |
| Q-Line Biotech Ltd | 1,569 | 27.8 | 22.5 % |
| Hemant Surgical Industries Ltd | 869 | 51.3 | 18.9 % |
| Vasa Denticity Ltd | 754 | 62.3 | 7.54 % |
| OSEL Devices Ltd | 691 | 23.6 | 24.4 % |
| Prevest Denpro Ltd | 462 | 20.5 | 24.9 % |
| QMS Medical Allied Services Ltd | 419 | 39.0 | 12.9 % |
| Nureca Ltd | 349 | 80.4 | 3.30 % |
| Aprameya Engineering Ltd | 200 | 39.7 | 12.6 % |
| Avience Biomedicals Ltd | 198 | 22.7 | 27.0 % |
| Earkart Limited | 179 | 36.3 | 17.5 % |
| Vaidya Sane Ayurved Laboratories Ltd | 176 | 19.6 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Laxmi Dental Ltd?
Laxmi Dental Ltd (LAXMIDENTL) has a market capitalisation of Rs 1,058 Cr. at the 2026-10-01 close.
What is the P/E ratio of Laxmi Dental Ltd?
Laxmi Dental Ltd trades at a P/E of 30.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were Laxmi Dental Ltd's latest quarterly results?
In the Jun 2026 quarter, Laxmi Dental Ltd sales was Rs 75 Cr (+13.6% vs Jun 2025) and net profit was Rs 10 Cr.
What is the 52-week high and low of Laxmi Dental Ltd?
The 52-week high is Rs 344.80 and the 52-week low is Rs 155.88.